The investigative therapy IONIS-HTTRx effectively reduced levels of the protein responsible for Huntington’s disease in early-stage patients, according to the…
Alice Melão
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melão
Mutations linked to Huntington’s disease cause more extensive remodeling of functional connectivity in various regions of the brain than previously…
A modified version of the genome-editing CRISPR-Cas9 system may prevent the production of faulty huntingtin protein, moving closer to treatment…
Nerve cells that mimic the molecular features of Huntington’s disease have been created from patients’ skin cells, researchers said.
Keeping a strict eating schedule may help improve the quality of life of patients with Huntington’s disease and other neurodegenerative…
MMJ BioScience has filed a patent invention with the U.S. Patent and Trademark Office for its part-cannabinoid treatment for patients…
The chemical compound manganese (Mn) has been reported to take part in the underlying mechanism of Alzheimer’s disease. However, little…
Embryonic stem cells have been seen as a potential therapeutic strategy for several diseases. However, the manipulation of these cells…
Activity and Levels of Enzyme Aco2 May Be Biomarker of Huntington’s Progression, Early Study Reports
A poorly active enzyme called aconitase 2 (Aco2), found at low levels in cells, can be a marker of the…
A Spanish study investigating the functioning of chloroplasts — the nutrient-producing “factory” of plants — has revealed a new mechanism…